Raphael Mechoulam

warning: Creating default object from empty value in /home/hemporg/public_html/news/modules/taxonomy/taxonomy.pages.inc on line 34.

Israel: Documentary Examines Professor Mechoulam's Pioneering Work With Cannabis

RaphaelMechoulam[PotNetwork.com]

The Scientist, a documentary released by filmmaker Zach Klein which aims to promote the work of Professor Raphael Mechoulam, is available online for free viewing.

Filmmaker Zach Klein first met Professor Mechoulam when researching the ways in which cannabis reduced the symptoms of chemotherapy that his mother was experiencing while being treated for breast cancer. The resulting documentary follows Professor Mechoulam's attempt to answer the potent question: Are we missing something?

While the work of Dr. Mechoulam in the cannabis field started way back in 1960, he maintained a humble attitude when it comes to the diffusion to the general public of the incredible discoveries he was able to publish. Only a few years ago Dr. Mechoulam agreed to grant an exclusive right to Zach Klein to produce a documentary about his lifetime achievements, to help spread the word and reach out to patients that suffer from medical conditions that can be treated with cannabinoids.

"Here we have a group of compounds, an endogenous system of major importance, it is not being used as much as it should be in the clinic, it is of great promise in the clinic," explained Dr. Mechoulam. "Let's try to push it forward and maybe this film can push it forward a bit."

The Scientist was produced, over period of four years, in association with Fundación CANNA, a non-profit research foundation focusing on the study of Cannabis and its compounds.

The Scientist is free to watch online through

Colorado: Marijuana Conference for Medical Professionals Set For Sept. 9-11

MarijuanaForMedicalProfessionals(logo)

When Todd Mitchem's mother was diagnosed with cancer a second time, her doctor told her that she had only six months remaining to put her affairs in order.

"That was a terrifying moment," Mitchem recalled. "Her doctor was so convinced of her prognosis that we began to accept the inevitable. Saying goodbye to my mother was going to be the hardest thing I could imagine doing."

At the time Mitchem's mother's doctor asked that she head to Pennsylvania to visit a wellness clinic and to undergo limited radiation. This visit could potentially extend her life as much as another month.

During this time Mitchem's mother found out about the many properties of marijuana, but in her state the plant was still illegal. Mitchem's mother began growing pot plants in her house and baking them into muffins with the hope that this self-treatment would extend her life a few extra and precious months.

That was six years ago and she is still alive today.

Todd Mitchem of Todd Mitchem Cannabis Consulting and CannaSearch LLC is on a mission to help doctors understand that they must learn about the benefits of cannabis in the body as a wellness medicine. "Doctors in many states now have a powerful medicine available to their patients if they will simply take the time to learn about cannabis," he said.

France: Cannabis Science, Inc. To Sponsor 3rd International Conference on Cannabinoids in Medicine

UFCMiCare(logo)

The third annual International Conference on Cannabinoids, a multilingual conference bringing together industry experts and stakeholders, will be held at the Faculty of Medicine of Strasbourg, France, on October 22.

Cannabis Science, Inc., a U.S. company specializing in cannabis formulation-based drug development and related consulting, on Friday announce its sponsorship of the conference, hosted by L'Union Francophone pour les Cannab inoides en Medecine (UFCM iCare). Researchers, health professionals, and patients will discuss the development of medical cannabis in Europe and North America.

"Cannabis Science is delighted to contribute to the UFCM iCare initiatives to encourage discussion and promote innovation in the medical cannabis arena as the company strives to move forward in bringing cannabinoid-based medicines to patients on a global basis," said Dorothy H. Bray, Ph.D., director, president and CEO of Cannabis Science, Inc.

French law provides for a regulatory framework for the research and development of cannabinoid-based medicine that will then be available to patients in mainstream pharmacies. The upcoming conference of international experts is intended to facilitate patient-driven dialog with the researchers and with the industry.

UFCM, the leading medical cannabis charity in France, has assembled a team of prominent speakers including Professor Raphael Mechoulam from the Hebrew University in Jerusalem in Israel and Professor Jerome Sèze from Department of Neurology, University Hospital of Strasbourg in France.

Israel: A Career In Cannabis

By Larry Derfner, Jewish Journal

There is a truth that must be heard! In nearly 50 years of researching the legendary powers of cannabis, Raphael Mechoulam, an 80-year-old chemistry professor at Jerusalem’s Hebrew University, says he’s only sampled the stuff himself once. That was in 1964 at his home in Tel Aviv.

"My wife baked a cake and my research partner and I spread THC (tetrahydrocannabinol, the oily, active ingredient in cannabis) on the top. We used 10 mg of THC on each slice – too much, I think – and we and a group of friends and colleagues started eating," says Mechoulam in his office in HU’s pharmacology labs.

"I felt a little high, but nothing more. My wife said she didn’t feel anything at all. One man said he didn’t feel anything, but started having laughing fits for the next hour. One woman had a bad trip – she was a very reserved person and suddenly she felt exposed in front of everyone. One man said he didn’t feel anything, but then didn’t stop talking for three hours, which I suppose was to be expected since he was a member of Knesset."

Global: Professor Raphael Mechoulam - Discovery of THC and Beyond

By Michael Bachara, Hemp News Staff

There is a truth that must be heard! Raphael Mechoulam is an Israeli professor for Medicinal Chemistry and Natural Products at the Hebrew University of Jerusalem in Israel. While working on research at the Weizmann Institute of Science, Michoulam succeeded in the isolation, structure elucidation and total synthesis of delta9-tetrahydrocannabinol, the main active principle of cannabis. He and his research group have also succeeded in the total synthesis of the major plant cannabinoids delta9-tetrahydrocannabinol, cannabidiol, cannabigerol and multiple others. Another research project initiated by him led to the isolation of the first described endocannabinoid anandamide which was isolated and characterized by two of his postdoctoral researchers, Lumír Hanuš and William Devane.

Over the past few years, Professor Mechoulam, has become a great inspiration to activists, doctors, scientists and citizens worldwide for his dedication and continual striving to find cures to devastating human ailments, such as PTSD and chronic pain.

Professor Mechoulam has been awarded several prizes from the Heinrich Wieland Prize to the Ulf von Euler Lecture in Physiology. In 1999, the International Cannabinoid Research Society established the "Raphael Mechoulam Annual Award in Cannabinoid Research".

Rhode Island: Accredited Medical Cannabis Therapeutics Conference - April 2010

Rhode Island: Accredited Medical Cannabis Therapeutics Conference - April 2010 The Sixth National Clinical Conference on Cannabis Therapeutics, co-sponsored by the School of Medicine, University of California at San Francisco; the Rhode Island State Nurses Association and Patients Out of Time will be held on April 15 - 17, 2010 at the Crowne Plaze Hotel in Warwick, RI.

Continuing education credits will be available through the University of California's Office of Continuing Medical Education.

Nursing contact hours have been applied for through the Rhode Island State Nurses Association and are pending approval.

Agenda - Sixth National Clinical Conference on Cannabis Therapeutics

Thursday April 15, 2010

7pm Reception & Exhibits

Friday, April 16, 2010

7:30 - Registration and Continental Breakfast

8:00 - Al Byrne - Welcome/Opening Remarks – Donald Abrams, MD (UCSF), Jesse Stout (RIPAC) and Donna Policastro, RN (RISNA)

8:30 - Raphael Mechoulam, PhD – Cannabis:Opening New Vistas in Both Therapy and Chemical Biology

9:10 - John McPartland, DO – A Molecular View of the Synergistic Shotgun

9:35 - Robert Melamede PhD– Endogenous Cannabinoid System Review

10:00 Break

10:20 - Gregory L. Gerdeman, PhD – Cannabinoids and the Neurobiology of Reward, Habit Formation and Addiction

10:45 - Andrea Hohmann, PhD – Endocannabinoid System & Neuropathic Pain

11:10 - Heather Bradshaw, PhD – The Endogenous Cannabinoid System and Reproductive Pain

Syndicate content